Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 65

1.

Novel antipsychotics: comparison of weight gain liabilities.

Wirshing DA, Wirshing WC, Kysar L, Berisford MA, Goldstein D, Pashdag J, Mintz J, Marder SR.

J Clin Psychiatry. 1999 Jun;60(6):358-63.

PMID:
10401912
2.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
3.

[Prescription of olanzapine in children and adolescent psychiatric patients].

Frémaux T, Reymann JM, Chevreuil C, Bentué-Ferrer D.

Encephale. 2007 Mar-Apr;33(2):188-96. Review. French.

PMID:
17675914
4.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
5.

Weight change and atypical antipsychotic treatment in patients with schizophrenia.

Jones B, Basson BR, Walker DJ, Crawford AM, Kinon BJ.

J Clin Psychiatry. 2001;62 Suppl 2:41-4. Review.

PMID:
11232752
6.

Atypical antipsychotics and weight gain--a systematic review.

Taylor DM, McAskill R.

Acta Psychiatr Scand. 2000 Jun;101(6):416-32. Review.

PMID:
10868465
7.

The promise of new drugs for schizophrenia treatment.

Tamminga CA.

Can J Psychiatry. 1997 Apr;42(3):265-73. Review.

PMID:
9114942
8.

Clinical efficacy of serotonin-dopamine antagonists relative to classic neuroleptics.

Borison RL.

J Clin Psychopharmacol. 1995 Feb;15(1 Suppl 1):24S-29S. Review.

PMID:
7537285
9.

Expected incidence of tardive dyskinesia associated with atypical antipsychotics.

Glazer WM.

J Clin Psychiatry. 2000;61 Suppl 4:21-6. Review.

PMID:
10739327
10.

[Cognition, schizophrenia and the effect of antipsychotics].

Stip E.

Encephale. 2006 May-Jun;32(3 Pt 1):341-50. Review. French.

PMID:
16840928
11.

Clozapine: a comparison with other novel antipsychotics.

Fleischhacker WW.

J Clin Psychiatry. 1999;60 Suppl 12:30-4. Review.

PMID:
10372608
12.
13.

Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis.

Rummel-Kluge C, Komossa K, Schwarz S, Hunger H, Schmid F, Lobos CA, Kissling W, Davis JM, Leucht S.

Schizophr Res. 2010 Nov;123(2-3):225-33. doi: 10.1016/j.schres.2010.07.012. Epub 2010 Aug 7. Review.

14.

Side effect profiles of new antipsychotic agents.

Casey DE.

J Clin Psychiatry. 1996;57 Suppl 11:40-5; discussion 46-52. Review.

PMID:
8941170
15.

Risperidone and olanzapine: optimal dosing for efficacy and tolerability in patients with schizophrenia.

Kasper S.

Int Clin Psychopharmacol. 1998 Nov;13(6):253-62. Review.

PMID:
9861575
16.

Clozapine in bipolar disorder: treatment implications for other atypical antipsychotics.

Frye MA, Ketter TA, Altshuler LL, Denicoff K, Dunn RT, Kimbrell TA, Corá-Locatelli G, Post RM.

J Affect Disord. 1998 Mar;48(2-3):91-104. Review.

PMID:
9543198
17.

Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia.

Kapur S, Remington G.

Annu Rev Med. 2001;52:503-17. Review.

PMID:
11160792
18.

Bodyweight gain with atypical antipsychotics. A comparative review.

Wetterling T.

Drug Saf. 2001 Jan;24(1):59-73. Review.

PMID:
11219487
19.

Olanzapine.

Hale AS.

Br J Hosp Med. 1997 Nov 5-18;58(9):442-5. Review.

PMID:
9619205
20.

The relationship of pharmacology to side effects.

Casey DE.

J Clin Psychiatry. 1997;58 Suppl 10:55-62. Review.

PMID:
9265918
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk